E/M Coding for 2021: What’s New and Different—Part 1 (Gastroenterology & Endoscopy News)
Some aspects of these revisions took effect for telehealth services since spring 2020 for Medicare, but now all payors should be adopting the changes.
14 Takeaways from Exact Sciences quarterly earnings call (NextServices)
The company expects to make $1.7 billion in revenues in 2021. COVID-19 testing contributed to $32.3 million.
63% of gastroenterologists saw a permanent decline in patient volume (Becker’s GI & Endoscopy)
Fifty-two percent of self-employed gastroenterologists saw a 1-25 percent decline in patient volume that they believe is permanent.
Medscape Gastroenterologist Compensation Report 2021 (Medscape)
While the worst business days are over for some physicians, others still struggle to recover.
USPSTF Final Recommendation on CRC Screening: 45 Is the New 50 (Medscape)
Screening for colorectal cancer in the US should now begin at the age of 45 in recognition of the growing number of adults under the age of 50 who are developing and dying from the disease.
Experts Caution on False Positives in AI (Gastroenterology & Endoscopy News)
Experts fear that emerging systems of computer-aided polyp detection may be generating so many false-positive findings that gastroenterologists who use the technology risk burnout.
Docbot Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021 (Valdosta Daily Times)
Title of presentation: Detection of Early Esophageal Neoplasia in Barrett’s Esophagus using Real-Time Artificial Intelligence: A Multicenter External Video Validation Study.
COVID’s Big Impact Made a Fairly Small Dent in GI Earnings (Medscape)
Despite the shutdowns and plummeting patient volumes early in the COVID-19 pandemic, gastroenterologists’ earnings were just 3.1% lower in 2020 than in 2019.
IBD Online: What Do Patients Search For? (Medscape)
The researchers suspected that social media users with IBD were looking for information they weren’t getting from their provider, so the researchers set out to identify those specific unmet needs.
Collaboration aims to improves diagnosis of gut health problems (MedTech Innovation)
Digestive health is also cited as one of the leading causes of work absenteeism and global direct and indirect costs are estimated at $21 billion annually.
EureKARE raises $60M to create EU synbio and microbiome startups (Fierce Biotech)
EureKARE has raised a $60 million series A round to fund the creation and advancement of synthetic biology and microbiome startups.
Specialty Excellence Awards 2021 Gastrointestinal Care (Healthgrades)
Healthgrades published its 2021 Specialty Excellence Awards on May 11 covering 16 service lines, including the top hospitals for gastrointestinal care.
Video: How COVID-19 transformed the future of medicine (TED.com)
Daniel Kraft explains how advancements like AI-infused antiviral discoveries and laboratory-level diagnostic tools accessible via smartphones are paving the way for a more connected and data-driven future of medicine.
ACG publishes guidelines for preferred treatment of C. difficile infection (Healio)
ACG developed guidelines for the preferred management of adults with Clostridioides difficile infection, published in the American Journal of Gastroenterology.
$3M ASC proposed in Vermont (Becker’s ASC Review)
The Collaborative Surgery Center will be about 9,000-square-feet with four operating rooms. It’s expected to be a multispecialty center.
Do self-employed or employed gastroenterologists earn more? (Becker’s GI & Endoscopy)
Self-employed gastroenterologists made $3,000 more annually than employed gastroenterologists.
Venture Firm Behind Livongo Launches $150 Million Consumer Health Fund (Forbes)
Livongo, the chronic disease management company incubated in Tullman and Shapiro’s offices, in an $18.5 billion deal, the duo’s firm has closed a $150 million fund to find the next digital health winner.
Post-COVID-19 GI Symptoms: Are We in for the Long Haul? (Medscape)
Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia, talks about the gastrointestinal (GI) manifestations of so-called long-haul COVID-19.